XML 31 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock (Tables)
9 Months Ended
Sep. 30, 2014
Equity [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following table provides a summary of the impact of our outstanding stock-based compensation plans on the results of operations for the periods presented:

 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
2014
 
2013
 
 
(in thousands)
 
 
 
 
 
 
 
 
 
Stock-based compensation expense
 
$
4,232

 
$
3,040

 
$
13,111

 
$
9,991

Income tax benefit
 
(1,482
)
 
(1,161
)
 
(4,856
)
 
(3,816
)
Net stock-based compensation expense
 
$
2,750

 
$
1,879

 
$
8,255

 
$
6,175

 
 
 
 
 
 
 
 
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
In January 2014, the Compensation Committee awarded 88,248 SARs to our executive officers. The fair value of each SAR award was estimated on the date of grant using a Black-Scholes pricing model using the following assumptions:

 
Nine Months Ended September 30,
 
2014
 
2013
 
 
 
 
Expected term of award
6 years

 
6 years

Risk-free interest rate
2.1
%
 
1.0
%
Expected volatility
65.6
%
 
65.5
%
Weighted-average grant date fair value per share
$
29.96

 
$
21.96

Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity
The following table presents the changes in our SARs:
 
Nine Months Ended September 30,
 
2014
 
2013
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term (in years)
 
Aggregate Intrinsic
Value
(in thousands)
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term
(in years)
 
Aggregate Intrinsic
Value
(in thousands)
Outstanding beginning of year, January 1,
190,763

 
$
33.77

 
 
 
 
 
118,832

 
$
30.80

 
 
 
 
Awarded
88,248

 
49.57

 
 
 
 
 
87,078

 
37.18

 
 
 
 
Outstanding at September 30,
279,011

 
38.77

 
8.0
 
$
3,215

 
205,910

 
33.50

 
8.4
 
$
5,363

Vested and expected to vest at September 30,
270,589

 
38.56

 
8.0
 
3,173

 
198,163

 
33.41

 
8.4
 
5,178

Exercisable at September 30,
109,920

 
32.71

 
7.1
 
1,933

 
67,069

 
29.99

 
7.3
 
1,982

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table presents the changes in non-vested time-based awards to all employees, including executive officers, for the nine months ended September 30, 2014:
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
 
 
 
 
Non-vested at December 31, 2013
651,781

 
$
36.36

Granted
284,705

 
56.64

Vested
(269,725
)
 
34.13

Forfeited
(30,536
)
 
41.67

Non-vested at September 30, 2014
636,225

 
46.13

 
 
 
 

The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:

 
As of/for the Nine Months Ended September 30,

 
2014
 
2013
 
(in thousands, except per share data)
 
 
 
 
Total intrinsic value of time-based awards vested
$
15,840

 
$
12,562

Total intrinsic value of time-based awards non-vested
31,996

 
38,774

Market price per common share as of September 30,
50.29

 
59.54

Weighted-average grant date fair value per share
56.64

 
44.56


Restricted Stock Awards, Market-Based, Valuation assumptions
In January 2014, the Compensation Committee awarded a total of 42,151 market-based restricted shares to our executive officers. In addition to continuous employment, the vesting of these shares is contingent on the Company's total shareholder return ("TSR"), which is essentially the Company’s stock price change including any dividends, as compared to the TSR of a set group of 15 peer companies. The shares are measured over a three-year period ending on December 31, 2016 and can result in a payout between 0% and 200% of the total shares awarded. The weighted-average grant date fair value per market-based share for these awards granted was computed using the Monte Carlo pricing model using the following assumptions:
 
 
Nine Months Ended September 30,
 
 
2014
 
2013
 
 
 
 
 
Expected term of award
 
3 years

 
3 years

Risk-free interest rate
 
0.8
%
 
0.4
%
Expected volatility
 
55.2
%
 
56.6
%
Weighted-average grant date fair value per share
 
$
56.87

 
$
49.04

Schedule of Nonvested Performance-based Units Activity
The following table presents the change in non-vested market-based awards during nine months ended September 30, 2014:

 
 
Shares
 
Weighted-Average
Grant-Date
Fair Value per Share
 
 
 
 
 
Non-vested at December 31, 2013
 
72,111

 
$
43.75

Granted
 
42,151

 
56.87

Non-vested at September 30, 2014
 
114,262

 
48.59

 
 
 
 
 

The following table presents the weighted-average grant date fair value per share and related information as of/for the periods presented:

 
As of/for the Nine Months Ended September 30,
 
2014
 
2013
 
(in thousands, except per share data)
 
 
 
 
Total intrinsic value of market-based awards non-vested
$
5,746

 
$
4,898

Market price per common share as of September 30,
50.29

 
59.54

Weighted-average grant date fair value per share
56.87

 
49.04